The Green List has a zero-tolerance for illegal listings or prescription products.
November 1st Highlights
The Green List Opinions Hits: 12
- Cannabis and Pharmaceuticals - Seniors are turning to cannabis to treat - Seniors are turning to cannabis to treat common symptoms of aging, with nearly 80% of those who reported using cannabis saying they did so for medicinal reasons, according to a study from researchers at the University of California San Diego. Results of the study, “Cannabis: An emerging treatment for common symptoms in older adults,” were published this month in the Journal of the American Geriatric Society. To conduct the research, investigators surveyed 568 seniors at a geriatric clinic. All respondents were at least 65 years old, and 73% of those surveyed were older than 75. The researchers discovered that 15% of seniors had used cannabis in the last three years, among whom half reported using cannabis regularly. Cannabis was used primarily for medical reasons by 78% of those who reported its use. Material sourced from here - link
- The EU Cannabis Advantage - Europe’s emerging infrastructure will be more equipped to enter GMP and pharmaceutical distribution networks than the U.S., since state-by-state rules didn’t require these higher standards of reporting and consistency to get mass distribution. Canada is already retooling facilities to conform to EU-GMP standards and it is costly and drawn out. The US will face this with federal regulation, and it will be an incredible set-back for existing grows and manufacturers to conform to regulatory needs. Australia is also in a similar position for Europe and eventually Asia. Material sourced from here - link